2021
Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data
Jackson CL, Colborn K, Gao D, Rao S, Slater HC, Parikh S, Foy BD, Kittelson J. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data. Clinical Trials 2021, 18: 582-593. PMID: 34218684, PMCID: PMC8478782, DOI: 10.1177/17407745211028581.Peer-Reviewed Original ResearchConceptsIvermectin mass drug administrationMass drug administrationCluster-randomized trialControl of malariaCluster-randomized trial designDrug AdministrationCrossover designMixed effects modelsTrial designStudy designCluster-level analysisSmall sample sizeCluster-level summariesCluster-level interventionsParallel trialRisk of harmPrimary analysisMalariaAdministrationMixed-effects modelsTrialsLevel interventionsSample sizeAdditional evaluationParallel design
2013
Malaria Diagnostics in Clinical Trials
Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR, Stewart VA. Malaria Diagnostics in Clinical Trials. American Journal Of Tropical Medicine And Hygiene 2013, 89: 824-839. PMID: 24062484, PMCID: PMC3820323, DOI: 10.4269/ajtmh.12-0675.Peer-Reviewed Original ResearchConceptsClinical trialsMalaria diagnosticsHuman immunodeficiency virus/Diagnostic testsMalaria clinical trialsVaccine clinical trialsMalaria diagnostic testsNatural history studiesRapid diagnostic testsHIV/malariaMalaria testStudy endpointInternational Working GroupVirus/Serologic testsEpidemiologic studiesTrial participantsMalaria diseaseNatural historyTrialsExternal quality assessmentMolecular assaysDiseaseHistory studiesLaboratory network